Table 4.
Prevalence of severe somatic, psychological and urogenital symptoms and OR (95% CI) for its association with menopausal status
| Severe somatic symptoms | Severe psychological symptoms | Severe urogenital symptoms | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Crude | Adjusteda | Crude | Adjusteda | Crude | Adjusteda | ||||
| N (%) | OR [95% CI] | OR [95% CI] | N (%) | OR [95% CI] | OR [95% CI] | N (%) | OR [95% CI] | OR [95% CI] | |
| Pre-menopause (N = 44) | 2 (4.5%) | 1 | 1 | 6 (13.6%) | 1 | 1 | 3 (6.8%) | 1 | 1 |
| Peri-menopause (N = 70) | 7 (10.0%) | 2.33 [0.46–11.82] | 3.79 [0.79–18.24] | 13 (18.6%) | 1.44 [0.54–3.89] | 2.31 [0.79–6.80] | 6 (8.6%) | 1.28 [0.38–5.22] | 1.00 [0.27–3.74] |
| Post-menopause (N = 137) | 10 (7.3%) | 1.65 [0.31–8.82] | 2.35 [0.45–12.86] | 28 (20.4%) | 1.63 [0.54–4.88] | 1.96 [0.47–8.08] | 34 (24.8%) | 4.51 [1.42–14.3] | 4.90 [1.74–13.84] |
| p value | 0.554 | 0.602 | 0.002 | ||||||
Bold values are statistically significant
OR: Odds Ratio from logistic regression for the association between menopausal status and the presence of severe menopausal symptoms in each MRS domain
aAdjusted for mode of transmission, current occupational status, smoking, drug use, social support, current partner